Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
Martin Metz(Charité - Universitätsmedizin Berlin), Marcus Maurer(Charité - Universitätsmedizin Berlin)
Cited by 135
Related Papers
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria
|Allergy Asthma and Immunology Research|2021|102